Ausverkauft, aber heiß begehrt!
Mehr zum Buch
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Buchkauf
The Pharmagellan Guide to Biotech Forecasting and Valuation, Andrew Matthews, Frank S. David, Seth Robey
- Sprache
- Erscheinungsdatum
- 2017
- product-detail.submit-box.info.binding
- (Paperback)
Wir benachrichtigen dich per E-Mail.
Hier könnte deine Bewertung stehen.
- Titel
- The Pharmagellan Guide to Biotech Forecasting and Valuation
- Sprache
- Englisch
- Autor*innen
- Andrew Matthews, Frank S. David, Seth Robey
- Verlag
- Pharmagellan
- Erscheinungsdatum
- 2017
- Einband
- Paperback
- Seitenzahl
- 138
- ISBN10
- 099840750X
- ISBN13
- 9780998407500
- Reihe
- Schlagwörter
- Sachbücher, Handel, Wirtschaft & Management, Ökonomie, Finanzen
- Bewertung
- 4,3 von 5 Sternen
- Beschreibung
- If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.